19
Views
136
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis

, , , &
Pages 321-329 | Received 13 May 1998, Accepted 15 Sep 1998, Published online: 28 Mar 2023

REFERENCES

  • Adari, H., D. R. Lowy, B. M. Willumsen, C. J. Der, and J. McCormick 1988. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240:518–521.
  • Alessi, D. R., Y. Saito, D. G. Campbell, P. Cohen, G. Sithanandam, U. Rapp, A. Ashworth, C. J. Marshall, and J. Cowley 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 13:1610–1619.
  • Bergers, G., P. Graninger, S. Braselmann, C. Wrighton, and J. Busslinger 1995. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15:3748–3758.
  • Betsholtz, C., A. Johnsson, C. H. Heldin, and J. Westermark 1986. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc. Natl. Acad. Sci. USA 83:6440–6444.
  • Brown, J. R., H. Ye, R. T. Bronson, P. Dikkes, and J. Greenberg 1996. A defect in nurturing in mice lacking the immediate early gene fosB. Cell 86:297–309.
  • Brusselbach, S., U. Mohle-Steinlein, Z.-Q. Wang, M. Schreiber, F. C. Lucibello, R. Muller, and J. Wagner 1995. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene 10:79–86.
  • Cheng, M., V. Sexl, C. J. Sherr, and J. Roussel 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091–1096.
  • Coffer, P., M. de Jonge, A. Mettouchi, B. Binetruy, J. Ghysdael, and J. Kruijer 1994. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 9:911–921.
  • Cohen, D. R., and J. Curran 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:2063–2069.
  • Cowley, S., H. Paterson, P. Kemp, and J. Marshall 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852.
  • Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and J. Hemmings 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–789.
  • Denhardt, D. T. 1996. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem. J. 318:729–747.
  • Dent, P., W. Haser, T. A. J. Haystead, L. A. Vincent, T. M. Roberts, and J. Sturgill 1992. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404–1406.
  • Diaz-Meco, M. T., J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz, and J. Moscat 1994. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 269:31706–31710.
  • Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and J. Saltiel 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686–7689.
  • Fukuda, M., I. Gotoh, M. Adachi, Y. Gotoh, and J. Nishida 1997. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. J. Biol. Chem. 272:32642–32648.
  • Fukuda, M., I. Gotoh, Y. Gotoh, and J. Nishida 1996. Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2 terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271:20024–20028.
  • Galang, C. K., C. J. Der, and J. Hauser 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements including tandem c-Ets-2 binding sites. Oncogene 9:2913–2921.
  • Gruda, M. C., K. Kovary, R. Metz, and J. Bravo 1994. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9:2537–2547.
  • Gruda, M. C., J. Vanamsterdam, C. A. Rizzo, S. K. Durham, A. Lira, and J. Bravo 1996. Expression of FosB during mouse development—normal development of FosB knockout mice. Oncogene 12:2177–2185.
  • Hai, T., and J. Curran 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720–3724.
  • Halazonetis, T. D., K. Georgopoulos, M. E. Greenberg, and J. Leder 1988. c-jun dimerizes with itself and with c-fos forming complexes with different binding affinities. Cell 55:917–924.
  • Hill, C. S., and J. Treisman 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199–211.
  • Hofer, F., S. Fields, C. Schneider, and J. Martin 1994. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci. USA 91:11089–11093.
  • Howe, L. R., S. J. Leevers, N. Gómez, S. Nakielny, P. Cohen, and J. Marshall 1992. Activation of the MAP kinase pathway by the protein kinase raf. Cell 71:335–342.
  • Hu, E., E. Mueller, S. Oliviero, V. E. Papaioannou, R. Johnson, and J. Spiegelmann 1994. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13:3094–3103.
  • Johnson, R. S., B. M. Spiegelman, and J. Papaioannou 1992. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577–586.
  • Joneson, T., M. A. White, M. H. Wigler, and J. Bar-Sagi 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science 271:810–812.
  • Kikuchi, A., S. D. Demo, Z. H. Ye, Y. W. Chen, and J. Williams 1994. ralGDS family members interact with the effector loop of Ras p21. Mol. Cell. Biol. 14:7483–7491.
  • Kovary, K., and J. Bravo 1991. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11:2451–2459.
  • Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch 1992. Raf-1 activates MAP kinase-kinase. Nature 358:417–421.
  • Leevers, S. J., and J. Marshall 1992. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11:569–574.
  • Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and J. Evan 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686–1690.
  • Lloyd, A. C., N. Yancheva, and J. Wasylyk 1991. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352:635–638.
  • Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and J. Ahn 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966–970.
  • Marais, R., J. Wynne, and J. Treismann 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381–393.
  • Martelli, P., E. G. Lapetina, C. J. Der, and J. White 1996. Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1. J. Biol. Chem. 271:29903–29908.
  • Martin, G. A., D. Viskochil, G. Bollag, P. C. McCabe, W. Crosier, H. Haubruck, L. Conroy, R. Clark, P. O’Connel, R. M. Cawthorn, M. A. Innis, and J. McCormick 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849.
  • McCarthy, S. A., D. Chen, B. S. Yang, R. J. Garcia, H. Cherwinski, X. R. Chen, M. Klagsbrun, C. A. Hauser, M. C. Ostrowski, and J. McMahon 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401–2412.
  • McCarthy, S. A., M. L. Samuels, C. A. Pritchard, J. A. Abraham, and J. McMahon 1995. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev 9:1953–1964.
  • Mechta, F., D. Lallemand, C. M. Pfarr, and J. Yaniv 1997. Transformation by ras modifies AP1 composition and activity. Oncogene 14:837–847.
  • Miao, G. G., and J. Curran 1994. Cell transformation by c-Fos requires an extended period of expression and is independent of the cell cycle. Mol. Cell. Biol. 14:4295–4310.
  • Morgenstern, J. P., and J. Land 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596.
  • Murakami, M., M. H. Sonobe, M. Ui, Y. Kabuyama, H. Watanabe, T. Wada, H. Handa, and J. Iba 1997. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene 14:2435–2444.
  • Nakielny, S., P. Cohen, J. Wu, and J. Sturgill 1992. MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J. 11:2123–2129.
  • Nishina, H., S. Hironori, S. Takeshi, S. Moriyuki, and J. Iba 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87:3619–3623.
  • Pagès, G., P. Lenormand, G. L’Allemain, J. C. Chambard, S. Meloche, and J. Pouysségur 1993. Mitogen-activated protein kinase p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319–8323.
  • Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and J. Koff 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:8–22.
  • Rauscher, F. J. III, P. J. Voulalas, B. R. Franza Jr., and J. Curran 1988. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev 2:1687–1699.
  • Roche, S., M. Koegl, and J. Courtneidge 1994. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 91:9185–9189.
  • Rodriguez, V. P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527–532.
  • Rodriguez, V. P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467.
  • Russell, M., C. C. Lange, and J. Johnson 1995. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J. Biol. Chem. 270:11757–11760.
  • Ryseck, R. P., and J. Bravo 1991. c-Jun, JunB and JunD differ in their binding affinities to AT-1 and CRE consensus sequences: effect of Fos proteins. Oncogene 6:533–542.
  • Samuels, M. L., M. J. Weber, M. Bishop, and J. McMahon 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13:6241–6252.
  • Schreiber, M., C. Poirier, A. Franchi, R. Kurzbauer, J.-L. Guenet, G. F. Carle, and J. Wagner 1997. Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis). Oncogene 15:1171–1178.
  • Sewing, A., B. Wiseman, A. C. Lloyd, and J. Land 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5588–5597.
  • Sonobe, M. H., T. Yoshida, M. Murakami, T. Kameda, and J. Iba 1995. fra-2 promoter can respond to serum-stimulation through AP-1 complexes. Oncogene 10:689–696.
  • Spaargaren, M., and J. Bischoff 1994. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc. Natl. Acad. Sci. USA 91:12609–12613.
  • van Aelst, L., M. Barr, S. Marcus, A. Polverino, and J. Wigler 1993. Complex formation between Ras and Raf and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213–6217.
  • van Aelst, L., M. White, and J. Wigler 1994. Ras partners. Cold Spring Harbor Symp. Quant. Biol. 59:181–186.
  • Van Dam, H., M. Duyndam, P. Pottier, A. Bosch, L. De Vries-Smits, P. Herrlich, A. Zantema, P. Angel, and J. van der Eb 1993. Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479–487.
  • Vlahos, C. J., W. F. Matter, K. Y. Hui, and J. Brown 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241–5248.
  • Vojtek, A. B., S. M. Hollenberg, and J. Cooper 1993. Mammalian Ras interacts directly with the serine threonine kinase Raf. Cell 74:205–214.
  • White, M. A., C. Nicolette, A. Minden, A. Polverino, A. L. Van, M. Karin, and J. Wigler 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533–541.
  • White, M. A., T. Vale, J. H. Camonis, E. Schaefer, and J. Wigler 1996. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras- induced transformation. J. Biol. Chem. 271:16439–16442.
  • Wolthuis, R. M., B. Bauer, L. J. van’t Veer, A. M. de Vries-Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. Burgering, and J. Bos 1996. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 13:353–362.
  • Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and J. McMahon 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598–5611.
  • Yoshioka, K., T. Deng, M. Cavigelli, and J. Karin 1995. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. USA 92:4972–4976.
  • Zhang, X. F., J. Settleman, J. M. Kyriakis, E. Takeuchi-Suzuki, S. J. Elledge, M. S. Marshall, J. T. Bruder, U. R. Rapp, and J. Avruch 1993. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364:308–313.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.